Table 2. Characteristics and clinical parameters of tongue squamous cell carcinoma patients and controls.

							Circulating miRNA
Patient ID	Gender	Age	TNM	Survival	Recurrence	Panel	Verification	miRNA tissue	Protein plasma	RNA tissue
35	F	24	T2N0M0	Dead	Yes			X		X*
56	F	41	T2N2bM0	Dead	Yes			X		X*
58	M	62	T1N0M0	Alive	No			X		X*
61	M	70	T4aN0M0	Alive	No	X	X	X	X	X*
65	F	81	T2N0M0	Alive	No	X	X	X	X	X*
68	M	62	T2N0M0	Dead	Yes	X	X		X	X*
73	M	81	T4aN0M0	Dead	No			X		X*
82	F	19	T4aN0M0	Dead	Yes	X	X		X	X*
83	F	64	T1N0M0	Alive	No	X	X	X	X
85	F	88	T2N0M0	Dead	Yes			X		X*
98	M	31	T2N0M0	Alive	No	X	X	X	X
99	M	65	T4aN2cM0	Alive	No	X	X		X
105	M	64	T1N0M0	Alive	No	X			X
111	F	31	T1N0M0	Alive	No	X	X	X	X
119	M	67	T2N0M0	Alive	No	X	X	X	X
124	M	54	T4N2bM0	Dead	Never TF	X	X	X	X
127	M	28	T1N0M0	Alive	No	X	X		X
131	F	74	T2N0M0	Alive	No	X	X	X	X
137 ¤	F	71	T2N0M0	Alive	No			X	X
138 ¤	M	50	T2N1M0	Alive	No			X	X
148 ¤	M	81	T1N0M0	Alive	No				X
149 ¤	F	69	T1N0M0	Alive	No				X
150 ¤	M	79	T3N0M0	Alive	No				X
154 ¤	F	42	T1N1M0	Alive	No				X

^*Data published in Boldrup et al, 2017 ([26])

^¤ Follow up time less than 2 years